Gerrit‐Jan Weverling

1.4k citations

20 papers · 1.1k indexed · h-index 15

Virology top 2%
- HIV Research and Treatment 10
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions 8
- HIV/AIDS drug development and treatment 6
- Tuberculosis Research and Epidemiology 1
Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 2
Oncology top 10%
Endocrinology top 10%
Emergency Medicine
- HIV-related health complications and treatments 3
Public Health, Environmental and Occupational Health
- Malaria Research and Control 3
Gastroenterology
- Gastroesophageal reflux and treatments 1

Co-authors: Nicole H. T. M. Dukers–Muijrers Jaap Goudsmit John de Wit Roel A. Coutinho Maria Prins Marco J. Bruno Djuna L. Cahen Paul Fockens
Cited by: Virology Infectious Diseases Epidemiology
Journals: The Lancet (1 paper)Gastroenterology (1 paper)American Journal of Epidemiology (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Gerrit‐Jan Weverling

20 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gerrit‐Jan Weverling

Since Specialization

Citations

This map shows the geographic impact of Gerrit‐Jan Weverling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit‐Jan Weverling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit‐Jan Weverling more than expected).

Fields of papers citing papers by Gerrit‐Jan Weverling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit‐Jan Weverling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit‐Jan Weverling. The network helps show where Gerrit‐Jan Weverling may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerrit‐Jan Weverling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit‐Jan Weverling Line = papers co-authored together Gerrit‐Jan Weverling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Endoscopic Drainage of Pancreatic Pseudocysts: Long-Term Outcome and Procedural Factors Associated with Safe and Successful Treatment Endoscopy ·Djuna L. Cahen,E RAUWS,Paul Fockens,Gerrit‐Jan Weverling,K. Huibregtse,Marco J. Bruno	2005	157
2	Adiponectin and glucose production in patients infected with Plasmodium falciparum Metabolism ·Regje M. E. Blümer,Huynh Van Thien,An F.C. Ruiter,Gerrit‐Jan Weverling,Dang vinh Thuan,Erik Endert,Piet A. Kager,Hans P. Sauerwein	2004	14
3	Free fatty acids increase hepatic glycogen content in obese males Metabolism ·Gideon Allick,F. Sprangers,Gerrit‐Jan Weverling,Mariëtte T. Ackermans,A.J. Meijer,Johannes A. Romijn,Erik Endert,Peter H. Bisschop,H. P. Sauerwein	2004	12
4	FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria American Journal of Physiology-Endocrinology and Metabolism ·Huynh Van Thien,Gerrit‐Jan Weverling,Mariëtte T. Ackermans,Nguyen Canh Hung,Erik Endert,Piet A. Kager,H.P. Sauerwein	2004	11
5	Gluconeogenesis and fasting in cerebral malaria. PubMed ·Huynh Van Thien,Mariëtte T. Ackermans,Gerrit‐Jan Weverling,T. Dang Vinh,Erik Endert,Piet A. Kager,H.P. Sauerwein	2004	5
6	AIDS Vaccines That Allow HIV-1 to Infect and Escape Immunologic Control JAIDS Journal of Acquired Immune Deficiency Syndromes ·Marijn van Ballegooijen,Johannes A. Bogaards,Gerrit‐Jan Weverling,Maarten C. Boerlijst,Jaap Goudsmit	2003	14
7	Influence of prolonged starvation on glucose kinetics in pregnant patients infected with Plasmodium falciparum Clinical Nutrition ·Huynh Van Thien,Mariëtte T. Ackermans,Gerrit‐Jan Weverling,Victor Chien,Erik Endert,Piet A. Kager,H. P. Sauerwein	2003	12
8	Legionnaires’ Disease at a Dutch Flower Show: Prognostic Factors and Impact of Therapy Emerging infectious diseases ·Kamilla D. Lettinga,Annelies Verbon,Gerrit‐Jan Weverling,Joop Schellekens,Jeroen W. Den Boer,Ed P. F. Yzerman,Jacobus Prins,Wim Boersma,R J van Ketel,Jan M. Prins,Peter Speelman	2002	70
9	Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort AIDS ·Jeanne P. Dieleman,Mariëlle Jambroes,Inge C. Gyssens,Miriam Sturkenboom,Bruno H. Stricker,W. Mulder,Frank de Wolf,Gerrit‐Jan Weverling,Joep M. A. Lange,Peter Reiss,Kees Brinkman	2002	67
10	Estimating the efficacy of interventions to prevent mother‐to‐child transmission of HIV in breast‐feeding populations: development of a consensus methodology Statistics in Medicine ·Ahmadou Alioum,François Dabis,L. Dequae-Merchadou,Geert Haverkamp,Michael G. Hudgens,James P. Hughes,John M. Karon,Valériane Leroy,Marie‐Louise Newell,Barbra A. Richardson,Gerrit‐Jan Weverling	2001	46
11	Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection AIDS ·Nicole H. T. M. Dukers–Muijrers,Jaap Goudsmit,John de Wit,Maria Prins,Gerrit‐Jan Weverling,Roel A. Coutinho	2001	205
12	Cerebrospinal fluid β2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor α receptors before and after treatment with lamivudine plus zidovudine or stavudine Journal of Neuroimmunology ·Roelien H. Enting,Norbert A. Foudraine,Joep M. A. Lange,Suzanne Jurriaans,Tom van der Poll,Gerrit‐Jan Weverling,Peter Portegies	2000	23
13	A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients AIDS ·Kiat Ruxrungtham,Eugène Kroon,Chaiwat Ungsedhapand,Somsong Teeratakulpisarn,Sasiwimol Ubolyam,Supranee Buranapraditkun,Remko van Leeuwen,Gerrit‐Jan Weverling,Chaiyos Kunanusont,Joep M. A. Lange,David A. Cooper,Praphan Phanuphak	2000	23
14	Risk Factors for Human Herpesvirus 8 Seropositivity and Seroconversion in a Cohort of Homosexula Men American Journal of Epidemiology ·Nicole H. T. M. Dukers–Muijrers,Neil Renwick,M. Prins,Ronald B. Geskus,Thomas F. Schulz,Gerrit‐Jan Weverling,R A Coutinho,Jaap Goudsmit	2000	119
15	Global view of helicobacter pylori associated gastritis Gastroenterology ·Yi Liu,Cyriel Y. Ponsioen,Gerrit‐Jan Weverling,Shudong Xiao,Guido N.J. Tytgat,Fiebo J. ten Kate	2000	2
16	HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial The Lancet ·Françoise Brun‐Vézinet,Charles A. Boucher,Clive Loveday,Diane Descamps,Veronique Fauveau,Jacques Izopet,Don Jeffries,Steve Kaye,Corinne Krzyanowski,Andrew Nunn,Rob Schuurman,Jean‐Marie Seigneurin,Catherine Tamalet,Richard S. Tedder,Jonathan Weber,Gerrit‐Jan Weverling	1997	96
17	Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma Journal of Clinical Microbiology ·Rob Schuurman,Diane Descamps,Gerrit‐Jan Weverling,Steve Kaye,Jolanda M.G.H. Tijnagel,Ian Williams,Remko van Leeuwen,Richard S. Tedder,Charles A. Boucher,F Brun-Vézinet,Clive Loveday	1996	93
18	Distinct Changes in HIV Type 1 RNA versus p24 Antigen Levels in Serum during Short-Term Zidovudine Therapy in Asymptomatic Individuals with and without Progression to AIDS AIDS Research and Human Retroviruses ·Suzanne Jurriaans,Gerrit‐Jan Weverling,Jaap Goudsmit,Jossy van den Boogaard,Melina G.H.E. den Brok,Dianne van Strijp,J Lange,M. Koot,Bob van Gemen	1995	20
19	Zidovudine and Interferon- Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection The Journal of Infectious Diseases ·P. H. J. Frissen,Marc van der Valk,Chris H.H. ten Napel,H Weigel,Gerrit Schreij,R. H. Kauffmann,P.P. Koopmans,Andy I. M. Hoepelman,Josien B. de Boer,Gerrit‐Jan Weverling,Gertrud L. G. Haverkamp,Pauline M. Dowd,Frank Miedema,R. Schuurman,Charles A. Boucher,J. M. A. Lange	1994	28
20	Evaluation of Different Tests for the Serodiagnosis of Tuberculosis and the Use of Likelihood Ratios in Serology American Review of Respiratory Disease ·Annelies Verbon,Gerrit‐Jan Weverling,Sjoukje Kuijper,Peter Speelman,H M Jansen,A H Kolk	1993	45

About Gerrit‐Jan Weverling

Gerrit‐Jan Weverling is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (6 papers), HIV-related health complications and treatments (3 papers), Malaria Research and Control (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Tuberculosis Research and Epidemiology (1 paper) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Virology (350 citations), Infectious Diseases (622 citations) and Epidemiology (395 citations). Gerrit‐Jan Weverling has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Nicole H. T. M. Dukers–Muijrers, Jaap Goudsmit, John de Wit, Roel A. Coutinho, Maria Prins, Marco J. Bruno, Djuna L. Cahen, Paul Fockens, E RAUWS and K. Huibregtse. Their work appears in journals such as The Lancet, Gastroenterology and American Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact